At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 22, 2026 at 08:02 ET
Taysha Gene Therapies, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency. This is a routine shareholder meeting announcement.
- TSHA is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency.
- The meeting is virtual and scheduled for June 1, 2026.
- This is a standard proxy statement filing for a routine annual shareholder meeting.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access